In April 2022, the Critical Path Institute (C-Path) and the European regulatory, industry and research community were excited to introduce « C-Path in Europe: Moving Global Regulatory Science Forward » as a webinar. The presentation highlighted how the nonprofit’s new headquarters in Amsterdam will continue to improve public health, share expertise, data, risks and costs to move…
PARIS, France and TUCSON, Ariz., U.S., February 1st, 2022: The European Joint Programme on Rare Diseases (EJP RD) announces a collaboration with the Critical Path Institute (C-Path), an independent global nonprofit organization, to advance technologies and methodologies that are fit for regulatory purposes to further global rare disease research and drug development. C-Path has a proven…
The Rare Disease Cures Accelerator–Data and Analytics Platform is launching a new webinar series with the goal of sharing with the community examples of the use of rare disease person-level data in drug development and regulatory decision making. The series will feature 1-hour webinars highlighting analyses that have been done in individual disease areas, how…